1x7q

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1x7q" size="450" color="white" frame="true" align="right" spinBox="true" caption="1x7q, resolution 1.45&Aring;" /> '''Crystal structure o...)
Line 1: Line 1:
-
[[Image:1x7q.gif|left|200px]]<br />
+
[[Image:1x7q.gif|left|200px]]<br /><applet load="1x7q" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1x7q" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1x7q, resolution 1.45&Aring;" />
caption="1x7q, resolution 1.45&Aring;" />
'''Crystal structure of HLA-A*1101 with sars nucleocapsid peptide'''<br />
'''Crystal structure of HLA-A*1101 with sars nucleocapsid peptide'''<br />
==Overview==
==Overview==
-
The structure of the human MHC-I molecule HLA-A*1101 in complex with a, nonameric peptide (KTFPPTEPK) has been determined by X-ray crystallography, to 1.45 A resolution. The peptide is derived from the SARS-CoV, nucleocapsid protein positions 362-370 (SNP362-370). It is conserved in, all known isolates of SARS-CoV and has been verified by in vitro, peptide-binding studies to be a good to intermediate binder to HLA-A*0301, and HLA-A*1101, with IC50 values of 70 and 186 nM, respectively, [Sylvester-Hvid et al. (2004), Tissue Antigens, 63, 395-400]. In terms of, the residues lining the peptide-binding groove, the HLA-A*1101-SNP362-370, complex is very similar to other known structures of HLA-A*1101 and, HLA-A*6801. The SNP362-370 peptide is held in place by 17 hydrogen bonds, to the alpha-chain residues and by nine water molecules which are also, tightly bound in the peptide-binding groove. Thr6 of the peptide (Thr6p), does not make efficient use of the middle (E) pocket. For vaccine, development, there seems to be a potential for optimization targeted at, this position. All residues except Thr2p and Lys9p are accessible for, T-cell recognition.
+
The structure of the human MHC-I molecule HLA-A*1101 in complex with a nonameric peptide (KTFPPTEPK) has been determined by X-ray crystallography to 1.45 A resolution. The peptide is derived from the SARS-CoV nucleocapsid protein positions 362-370 (SNP362-370). It is conserved in all known isolates of SARS-CoV and has been verified by in vitro peptide-binding studies to be a good to intermediate binder to HLA-A*0301 and HLA-A*1101, with IC50 values of 70 and 186 nM, respectively [Sylvester-Hvid et al. (2004), Tissue Antigens, 63, 395-400]. In terms of the residues lining the peptide-binding groove, the HLA-A*1101-SNP362-370 complex is very similar to other known structures of HLA-A*1101 and HLA-A*6801. The SNP362-370 peptide is held in place by 17 hydrogen bonds to the alpha-chain residues and by nine water molecules which are also tightly bound in the peptide-binding groove. Thr6 of the peptide (Thr6p) does not make efficient use of the middle (E) pocket. For vaccine development, there seems to be a potential for optimization targeted at this position. All residues except Thr2p and Lys9p are accessible for T-cell recognition.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
1X7Q is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with SO4 and GOL as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1X7Q OCA].
+
1X7Q is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=SO4:'>SO4</scene> and <scene name='pdbligand=GOL:'>GOL</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1X7Q OCA].
==Reference==
==Reference==
Line 20: Line 19:
[[Category: Buus, S.]]
[[Category: Buus, S.]]
[[Category: Gajhede, M.]]
[[Category: Gajhede, M.]]
-
[[Category: Kastrup, J.S.]]
+
[[Category: Kastrup, J S.]]
[[Category: GOL]]
[[Category: GOL]]
[[Category: SO4]]
[[Category: SO4]]
Line 31: Line 30:
[[Category: sars]]
[[Category: sars]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:01:48 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:51:51 2008''

Revision as of 13:51, 21 February 2008


1x7q, resolution 1.45Å

Drag the structure with the mouse to rotate

Crystal structure of HLA-A*1101 with sars nucleocapsid peptide

Contents

Overview

The structure of the human MHC-I molecule HLA-A*1101 in complex with a nonameric peptide (KTFPPTEPK) has been determined by X-ray crystallography to 1.45 A resolution. The peptide is derived from the SARS-CoV nucleocapsid protein positions 362-370 (SNP362-370). It is conserved in all known isolates of SARS-CoV and has been verified by in vitro peptide-binding studies to be a good to intermediate binder to HLA-A*0301 and HLA-A*1101, with IC50 values of 70 and 186 nM, respectively [Sylvester-Hvid et al. (2004), Tissue Antigens, 63, 395-400]. In terms of the residues lining the peptide-binding groove, the HLA-A*1101-SNP362-370 complex is very similar to other known structures of HLA-A*1101 and HLA-A*6801. The SNP362-370 peptide is held in place by 17 hydrogen bonds to the alpha-chain residues and by nine water molecules which are also tightly bound in the peptide-binding groove. Thr6 of the peptide (Thr6p) does not make efficient use of the middle (E) pocket. For vaccine development, there seems to be a potential for optimization targeted at this position. All residues except Thr2p and Lys9p are accessible for T-cell recognition.

Disease

Known diseases associated with this structure: Abacavir hypersensitivity, susceptibility to OMIM:[142800], Ankylosing spondylitis, susceptibility to, 1 OMIM:[142800], Hypoproteinemia, hypercatabolic OMIM:[109700], Stevens-Johnson syndrome, susceptibility to OMIM:[142800]

About this Structure

1X7Q is a Protein complex structure of sequences from Homo sapiens with and as ligands. Full crystallographic information is available from OCA.

Reference

High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide., Blicher T, Kastrup JS, Buus S, Gajhede M, Acta Crystallogr D Biol Crystallogr. 2005 Aug;61(Pt 8):1031-40. Epub 2005, Jul 20. PMID:16041067

Page seeded by OCA on Thu Feb 21 15:51:51 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools